The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Amyloid PET imaging in patients with mild cognitive impairment: A 2-year follow-up study
Abstract
BACKGROUND: Patients with amnestic mild cognitive impairment (MCI) have greater risk of conversion to Alzheimer disease (AD). Increased brain amyloid burden in AD and MCI has been demonstrated with PET using [(11)C] Pittsburgh compound B (PiB) as a tracer. OBJECTIVE: To evaluate change in β-amyloid deposition in with MCI during 2-year follow-up. METHODS: Patients with MCI and controls were studied with [(11)C] PiB PET, MRI, and neuropsychometry at baseline and these investigations were repeated in patients with MCI after follow-up. RESULTS: Those patients with MCI converting to AD during follow-up had greater [(11)C] PiB retention in the posterior cingulate (p=0.020), in the lateral frontal cortex (p=0.006), in the temporal cortex (p=0.022), in the putamen (p=0.041), and in the caudate nucleus (p=0.025) as compared to nonconverters. In converters, there was no significant change in [(11)C] PiB uptake, whereas an increase was seen as compared to baseline in nonconverters in the anterior and posterior cingulate, temporal and parietal cortices, and putamen. Hippocampal atrophy was greater in converters at baseline than in nonconverters, but increased significantly in both groups during follow-up. CONCLUSIONS: Hippocampal atrophy and amyloid deposition seem to dissociate during the evolution of MCI, the atrophy increasing clearly and [(11)C] PiB retention changing modestly when conversion to AD occurs. Longer follow-up is needed to determine whether nonconverters would convert to AD later, which would suggest accelerated [(11)C] PiB retention preceding clinical conversion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“indicating a fundamental participation of microglia in the development and progression of AD.”
From Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation (2019) · cites this paper as [151]
In the citing paper
“PET imaging studies have shown that subjects with high amounts of amyloid-β, but no dementia, had decreased microglia activation [151–153]”
From Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation (2019) · cites this paper as [151]
Citations
Cites
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Scheltens, P., Leys, D., Barkhof, F., Huglo, D. G., Weinstein, H. C., Vermersch, P., Kuiper, M. A., Steinling, M., Wolters, E. C., & Valk, J. (1992) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.10.967 · Cited by 1,816
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
Jack, C. R., Petersen, R. C., Xu, Y. C., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Waring, S. C., Tangalos, E. G., & Kokmen, E. (1999) · Neurology · doi:10.1212/wnl.52.7.1397 · Cited by 1,404
Jack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., et al. (2009) · Brain · doi:10.1093/brain/awp062 · Cited by 1,099
[ 11 C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease
Mintun, M. A., LaRossa, G. N., Sheline, Y. I., Dence, C. S., Lee, S. Y., Mach, R. H., Klunk, W. E., Mathis, C. A., DeKosky, S. T., & Morris, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000228230.26044.a4 · Cited by 1,036
Jack, C. R., Lowe, V. J., Senjem, M. L., Weigand, S. D., Kemp, B. J., Shiung, M. M., Knopman, D. S., Boeve, B. F., Klunk, W. E., Mathis, C. A., et al. (2008) · Brain · doi:10.1093/brain/awm336 · Cited by 958
Pike, K. E., Savage, G., Villemagne, V. L., Ng, S., Moss, S. A., Maruff, P., Mathis, C. A., Klunk, W. E., Masters, C. L., & Rowe, C. C. (2007) · Brain · doi:10.1093/brain/awm238 · Cited by 789
Reiman, E. M., Chen, K., Liu, X., Bandy, D., Yu, M., Lee, W., Ayutyanont, N., Keppler, J., Reeder, S. A., Langbaum, J. B. S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900345106 · Cited by 785
PET imaging of amyloid deposition in patients with mild cognitive impairment
Forsberg, A., Engler, H., Almkvist, O., Blomquist, G., Hagman, G., Wall, A. E., Ringheim, A., Långström, B., & Nordberg, A. K. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.029 · Cited by 725
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
Engler, H., Forsberg, A., Almkvist, O., Blomquist, G., Larsson, E., Savitcheva, I., Wall, A. E., Ringheim, A., Långström, B., & Nordberg, A. K. (2006) · Brain · doi:10.1093/brain/awl178 · Cited by 614
Cited by
Sorted by citations
Items 101–188 of 188
Application of the IWG-2 Diagnostic Criteria for Alzheimer’s Disease to the ADNI
Wang, H.-F., Initiative, A. A. D. N., Tan, L., Cao, L., Zhu, X., Jiang, T., Tan, M., Liu, Y., Wang, C., Tsai, R. M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150824 · Cited by 18
Relationship of Hippocampal Volume to Amyloid Burden across Diagnostic Stages of Alzheimer's Disease
Trzepacz, P. T., Hochstetler, H. M., Yu, P., Castelluccio, P., Witte, M. M., Dell’Agnello, G., Degenhardt, E. K., & Initiative, A. D. N. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000441351 · Cited by 15
Barć, K., & Kuźma‐Kozakiewicz, M. (2019) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2019.0013 · Cited by 15
Palmomental Reflex a Relevant Sign in Early Alzheimer’s Disease Diagnosis?
Gabelle, A., Gutierrez, L., Dartigues, J., Ritchie, K. A., Touchon, J., & Berr, C. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150436 · Cited by 16
Biomarcadores en la enfermedad de Alzheimer
Ribas, G. G., López-Sendón, J. L., & Caldentey, J. G. (2014) · Revista de Neurología · doi:10.33588/rn.5807.2013394 · Cited by 14
Zhao, Q. X., Du, X., Chen, W., Zhang, T., & Xu, Z. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1216215 · Cited by 17
Duff, K. M., Hammers, D. B., Koppelmans, V., King, J. B., & Hoffman, J. M. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231392 · Cited by 13
Booij, J., Arbizu, J., Darcourt, J., Hesse, S., Nobili, F. M., Payoux, P., Pappatà, S., Tatsch, K., Walker, Z., & Pagani, M. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2415-x · Cited by 13
Concordance Between 11 C-PIB-PET and Clinical Diagnosis in a Memory Clinic
Patricio, C. M., Cohen, G., Russo, J., Suarez, M. F., Nahas, F., Russo, G., Claudio, W., Santiago, P., Leonardo, T., Jorge, C., et al. (2015) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317515576387 · Cited by 13
Deep brain stimulation in Alzheimer's disease
Fontaine, D., & Santucci, S. (2021) · International review of neurobiology · doi:10.1016/bs.irn.2021.06.005 · Cited by 13
Malpas, C. B., Saling, M. M., Velakoulis, D., Desmond, P. M., & O'Brien, T. J. (2015) · Neurodegenerative Diseases · doi:10.1159/000438924 · Cited by 12
Biomarker changes associated with fornix deep brain stimulation in Alzheimer's disease
Germann, J., Amaral, R. S. C., Tomaszczyk, J. C., Yamamoto, K., Elias, G. J. B., Gouveia, F. V., Vasilevskaya, A., Taghdiri, F., Devenyi, G. A., Sankar, T., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70394 · Cited by 11
Kaskikallio, A., Karrasch, M., Rinne, J. O., Tuokkola, T., Parkkola, R. K., & Grönholm-Nyman, P. (2019) · Aging Neuropsychology and Cognition · doi:10.1080/13825585.2019.1628916 · Cited by 13
Self-citationAmyloid imaging in Alzheimer's disease: A literature review
Saidlitz, P., Voisin, T., Vellas, B. J., Payoux, P., Gabelle, A., Formaglio, M., & Delrieu, J. (2014) · The journal of nutrition health & aging · doi:10.1007/s12603-014-0507-3 · Cited by 12
Braverman, E. R., Blum, K., Damle, U. J., Kerner, M., Dushaj, K., & Oscar‐Berman, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055398 · Cited by 11
Amyloid deposition and CBF patterns predict conversion of mild cognitive impairment to dementia
Kikukawa, T., Abe, T., Ataka, S., Saito, H., Hasegawa, I., Mino, T., Takeuchi, J., Kawabe, J., Wada, Y., Watanabe, Y., et al. (2018) · Neurological Sciences · doi:10.1007/s10072-018-3477-0 · Cited by 12
Kitajima, K., Abe, K., Takeda, M., Yoshikawa, H., Ohigashi, M., Osugi, K., Koyama, H., & Yamakado, K. (2021) · Medicine · doi:10.1097/md.0000000000023969 · Cited by 10
Lee, D., Kang, H., Kim, E., Lee, H., Kim, H., Kim, Y. K., Lee, Y., & Lee, D. S. (2015) · BMC Medical Research Methodology · doi:10.1186/1471-2288-15-9 · Cited by 10
Kemppainen, N. M., Joutsa, J., Johansson, J. J., Scheinin, N. M., Någren, K., Rokka, J., Parkkola, R. K., & Rinne, J. O. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150190 · Cited by 9
Self-citationEffects of White Matter Hyperintensities on Verbal Fluency in Healthy Older Adults and MCI/AD
Kaskikallio, A., Karrasch, M., Koikkalainen, J. R., Lötjönen, J. M. P., Rinne, J. O., Tuokkola, T., Parkkola, R. K., & Grönholm-Nyman, P. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.614809 · Cited by 9
Self-citationA variant of sparse partial least squares for variable selection and data exploration
Hunt, M. J. O., Weissfeld, L. A., Boudreau, R. M., Aizenstein, H. J., Newman, A. B., Simonsick, E. M., Domelen, D. R. V., Thomas, F., Yaffe, K. S., & Rosano, C. (2014) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2014.00018 · Cited by 10
Gulyás, B. Z., Spenger, C., Beliczai, Z., Gulya, K., Kása, P., Jahan, M., Jia, Z., Weber, U., Pfeifer, A., Muhs, A., et al. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.10.010 · Cited by 9
Park, H., Lee, J.-Y., Yang, J.-J., Kim, H., Kim, Y. S., Kim, J. Y., & Choi, Y.-Y. (2023) · Journal of the Korean Society of Radiology · doi:10.3348/jksr.2022.0084 · Cited by 8
A 5-year longitudinal evaluation in patients with mild cognitive impairment by 11C-PIB PET/CT
Jiménez-Bonilla, J. F., Quirce, R., de Arcocha-Torres, M., Martínez‐Rodríguez, I., Martínez‐Amador, N., Sánchez-Salmón, A., la Fuente-Gómez, F. D., Rodríguez‐Rodríguez, E., Sánchez‐Juan, P., & Banzo, I. (2019) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000001004 · Cited by 8
Beyer, L., Initiative, A. D. N., Brendel, M., Scheiwein, F., Sauerbeck, J., Hosakawa, C., Alberts, I., Shi, K., Bartenstein, P., Ishii, K., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-190818 · Cited by 8
Mackin, R. S., Rhodes, E., Kassel, M. T., Kryza‐Lacombe, M., Burns, E., Bickford, D. D., Morin, R. T., Tosun, D., Landau, S. M., Butters, M. A., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02677-4 · Cited by 8
Jiménez-Bonilla, J. F., Banzo, I., de Arcocha-Torres, M., Quirce, R., Martínez‐Rodríguez, I., Lavado-Pérez, C., Bravo-Ferrer, Z., Rodríguez‐Rodríguez, E., Sánchez‐Juan, P., & CARRIL, J. M. (2016) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000569 · Cited by 7
Vers une nouvelle définition de la maladie d’Alzheimer
Dubois, B. (2013) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)31632-2 · Cited by 6
Genetic and degenerative disorders primarily causing dementia
Masdeu, J. C., & Pascual, B. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53485-9.00026-x · Cited by 6
Camarda, C., Torelli, P., Pipia, C., Battaglini, I., Azzarello, D. M., Rosano, R., Ventimiglia, C. C., Sottile, G., Cilluffo, G., & Camarda, R. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190726100744 · Cited by 6
Isolated, Subtle Neurological Abnormalities in Mild Cognitive Impairment Types
Camarda, C., Camarda, R., Pipia, C., Azzarello, D. M., Grassedonio, E., Sottile, G., Cilluffo, G., & Torelli, P. (2019) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2019.293 · Cited by 6
Clinical Assessment of Amyloid Imaging in Alzheimer's Disease: A Systematic Review of the Literature
Wahlster, P., Niederländer, C., Kriza, C., Schaller, S., & Kolominsky‐Rabas, P. L. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000351679 · Cited by 8
PET and SPECT Imaging of Neurodegenerative Diseases
Drzezga, A. E., Bischof, G. N., Giehl, K., & van Eimeren, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816386-3.00085-5 · Cited by 4
Rauhala, E., Johansson, J. J., Karrasch, M., Eskola, O., Tolvanen, T., Parkkola, R. K., Virtanen, K. A., & Rinne, J. O. (2022) · EJNMMI Research · doi:10.1186/s13550-022-00928-5 · Cited by 4
Self-citationWang, D., Xu, K., Dang, M., Sang, F., Chen, K., Zhang, Z., & Li, X. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad369 · Cited by 4
Langley, J. A., Bennett, I. J., Hu, X. P., & Initiative, A. D. N. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16362 · Cited by 4
Tada, T., Hara, K., Fujita, N., Ito, Y., Yamaguchi, H., Ohdake, R., Kawabata, K., Ogura, A., Kato, T., Yokoi, T., et al. (2023) · Annals of Nuclear Medicine · doi:10.1007/s12149-023-01843-y · Cited by 4
Zhu, Y., Zang, F., Liu, X., Fan, D., Zhang, Q., Ren, Q., Xie, C., & Initiative, A. D. N. (2020) · Brain Imaging and Behavior · doi:10.1007/s11682-020-00316-4 · Cited by 4
Using Pittsburgh Compound B For Pet Imaging Across the Alzheimer’s Disease Spectrum
Cohen, A. D. (2016) · Technology & Innovation · doi:10.21300/18.1.2016.51 · Cited by 4
New objective simple evaluation methods of amyloid PET/CT using whole-brain histogram and Top20%-Map
Okuyama, C., Higashi, T., Ishizu, K., Oishi, N., Kusano, K., Ito, M., Kagawa, S., Okina, T., Suzuki, N., Hasegawa, H., et al. (2024) · Annals of Nuclear Medicine · doi:10.1007/s12149-024-01956-y · Cited by 3
Les marqueurs de la maladie d’Alzheimer prodromale
de Souza, L. C., Sarazin, M., Uspenskaya, O., Habert, M., Lamari, F., Lehéricy, S., & Dubois, B. (2012) · Revue Neurologique · doi:10.1016/j.neurol.2012.07.005 · Cited by 6
alzheimer disease: New Concepts on Its Neurobiology and the Clinical
Jack, C. R., & Cme, O. (2012) · Cited by 3
Molecular medicine: a path towards a personalized medicine
de Miranda, D. M., Mamede, M. H., Souza, B. R., Barros, A. G. D. A., Magno, L. A. V., Alvim-Soares, A., Rosa, D. V., de Castro, C. J., Malloy‐Diniz, L. F., Gomez, M. V., et al. (2012) · Brazilian Journal of Psychiatry · doi:10.1016/s1516-4446(12)70015-6 · Cited by 5
Trajectories of late-life depression: insights from molecular imaging
Holmes, S. E., & Smith, G. S. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02340-2 · Cited by 2
PET Tracers for Beta-Amyloid and Other Proteinopathies
Nordberg, A. K. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_8 · Cited by 2
Amyloid imaging for Alzheimer's disease
Kerchner, G. A. (2011) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2011.617365 · Cited by 2
Update Amyloid-Bildgebung in der Diagnostik der Neurodegeneration
Drzezga, A. E., & Giehl, K. (2022) · Angewandte Nuklearmedizin · doi:10.1055/a-1712-6110 · Cited by 1
Can Structural MRIs be used to Detect Amyloid Positivity using Deep Learning?
Chattopadhyay, T., Komandur, D., Naik, J., Buwa, K., Ozarkar, S. S., Thomopoulos, S. I., & Thompson, P. M. (2023) · International Symposium on Medical Information Processing and Analysis (SIPAIM) · doi:10.1109/sipaim56729.2023.10373510 · Cited by 1
Dementia Due to Neurodegenerative Disease: Molecular Imaging Findings
Ossenkoppele, R., Booij, J., Scheltens, P., & van Berckel, B. N. M. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_9 · Cited by 1
Amyloid imaging in depression: a predictor of Alzheimer’s disease?
Camacho, V., & Lleó, A. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2741-7 · Cited by 1
Ashraf, A., Mehta, P. D., & Edison, P. (2012) · Reviews in Clinical Gerontology · doi:10.1017/s0959259812000160 · Cited by 1
Advances in Alzheimer’s Disease Management
Gauthier, S. G., & Rosa‐Neto, P. (2012) · doi:10.2217/9781780840840 · Cited by 1
PET in Neurological and Psychiatric Disorders: Technologic Advances and Clinical Applications
Matusch, A., & Kroll, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-40070-9_20 · Cited by 1
Neuroimaging Advances in Alzheimer's Disease
Schonhaut, D. R., & Rabinovici, G. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800105-9.00017-2 · Cited by 1
Impact of the New Conceptual Framework of Alzheimer’s Disease in Imaging Studies
Dubois, B., Villain, N., Jacova, C., & Uspenskaya, O. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_13 · Cited by 1
PET and SPECT Studies of Ageing and Cardiovascular Risk Factors for Alzheimer’s Disease
Busatto, G. F., Tamashiro-Duran, J. H., de Toledo, T. C., Ferreira, L. K., Duran, F., & Buchpiguel, C. A. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_21
Sian, M., & Lee, T.-S. W. (2013) · InTech eBooks · doi:10.5772/54289
Apport de l’imagerie par résonance magnétique dans la maladie d’Alzheimer
Lehéricy, S., Boutet, C., de Souza, L. C., Marie Chupin, A., Olivier Colliot, A., Sarazin, M., & Dormont, D. (2013) · Springer eBooks · doi:10.1007/978-2-8178-0443-9_3
Diagnosticare la malattia di Alzheimer
Sarazin, M., Hamelin, L., Lamari, F., & Bottlaender, M. (2014) · EMC - Neurologia · doi:10.1016/s1634-7072(14)67223-8
Impact of the IWG/Dubois Criteria for Alzheimer’s Disease in Imaging Studies
Dubois, B., & Uspenskaya, O. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_13
Wang, X. R. (2015) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/27084
Imagerie de l’Alzheimer : quoi de neuf ?
Payoux, P. (2013) · Médecine Nucléaire · doi:10.1016/j.mednuc.2013.03.043
Zerebrale Bildgebung bei Demenzen: State-of-the-Art Brain Imaging in Dementia: State-of-the-Art
Boelmans, K., & Buchert, R. (2013)
VARIANCE OF THE AMYLOID BETA PEPTIDE AS A METRIC FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE
Beckett, C. (2016) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2016.161
Drzezga, A. E. (2016) · Springer eBooks · doi:10.1007/978-3-319-30081-8_26
Dillon, C., Leguizamon, P. P., Heisecke, S. L., Castro, D. M., López‐Camelo, J. S., Loñ, L., Serrano, C. M., Guelar, V., & Taragano, F. E. (2016) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v6i10.299
Diagnostiquer la maladie d'Alzheimer
Sarazin, M., Hamelin, L., Lamari, F., & Bottlaender, M. (2013)
Memory decline and Aβ amyloid as markers of neurodegeneration in preclinical Alzheimer's disease
Lim, Y. Y. (2013) · Minerva Access (University of Melbourne)
Diagnosis of Alzheimer’s disease
Rosa‐Neto, P., Rowley, J., Leuzy, A., Mohades, S., Shin, M., Dauar, M. T., & Gauthier, S. G. (2012) · doi:10.2217/ebo.12.66
Diagnosi clinicolaboratoristica della malattia di Alzheimer
Lagarde, J., Olivieri, P., Bottlaender, M., & Sarazin, M. (2021) · EMC - Neurologia · doi:10.1016/s1634-7072(21)45320-1 · Cited by 1
Amyloid imaging in alzheimer’s disease: A literature review
Saidlitz, P., Voisin, T., Vellas, B. J., Payoux, P., Gabelle, A., Formaglio, M., & Delrieu, J. (2014) · The journal of nutrition health & aging · doi:10.1007/s12603-014-0485-5
Kilimann, I., & Teipel, S. J. (2019) · Elsevier eBooks · doi:10.1016/b978-3-437-21882-8.00014-1
Nordberg, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-397025-1.00071-3
(2013) · Elsevier eBooks · doi:10.1016/b978-0-12-410407-5.16001-5
Geeraerts, T., & Menon, D. K. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-0167-8.00029-7
Drzezga, A. E., & Giehl, K. (2023) · Springer eBooks · doi:10.1007/978-3-031-35098-6_5
(2022) · Elsevier eBooks · doi:10.1016/b978-3-437-21884-2.00033-7
O’Dell, R. S., Mecca, A. P., Chen, M.-K., Naganawa, M., Toyonaga, T., Lu, Y., Godek, T. A., Harris, J. E., Bartlett, H. H., Banks, E. R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13525170
O’Dell, R. S., Mecca, A. P., Chen, M.-K., Naganawa, M., Toyonaga, T., Lu, Y., Godek, T. A., Harris, J. E., Bartlett, H. H., Banks, E. R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13525173
Tomadesso, C. (2018) · theses.fr (ABES) · doi:10.70675/7fad6418zff81z49c7z984dz63aa2e44d7fc
Développement d’un test sanguin pour le dépistage de la maladie d’Alzheimer
Torres, F. D. (2022) · theses.fr (ABES) · doi:10.70675/afbb97a5z1636z46abz844czb340616aeda1
Lim, S., Lee, Y., Yun, C., Kim, K., Yun, C., & Initiative, A. D. N. (2026) · Annals of Neurology · doi:10.1002/ana.78301
Rauhala, E., Johansson, J., Karrasch, M., Eskola, O., Tolvanen, T., Rajander, J., & Rinne, J. O. (2026) · Aging Brain · doi:10.1016/j.nbas.2026.100165
Self-citationLista, S., Filippi, L., Emanuele, E., López‐Ortiz, S., Cisale, G. Y., Minoretti, P., Garaci, F. G., & Santos‐Lozano, A. (2026) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-026-00879-w
The relation of whole-brain functional connectivity to global amyloid and local tau presence
Ziadlou, D., Wales, R., Chen, X., & Leung, H.-C. (2026) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2026.10.007
Metadata
- Authors
- Koivunen, J., Scheinin, N., Virta, J. R., Aalto, S., Vahlberg, T., Någren, K., Helin, S., Parkkola, R., Viitanen, M., & Rinne, J. O.
- Affiliations
- University of Turku (FI)
- ORCID
- Venue
- Neurology
- Published
- 2011-03-22
- Volume
- 76
- Issue
- 12
- Pages
- 1085-1090
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2143282099
- Cited by
- 188
- References
- 18
- Citations by year
- 2026: 6 · 2025: 1 · 2024: 4 · 2023: 6 · 2022: 6 · 2021: 11 · 2020: 5 · 2019: 12 · 2018: 9 · 2017: 8 · 2016: 12 · 2015: 12 · 2014: 27 · 2013: 30 · 2012: 32
- FWCI
- 21.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Keywords
- amnestic mild cognitive impairment, amyloid-beta deposition, Pittsburgh compound B, amyloid PET, hippocampal atrophy, posterior cingulate cortex, temporal cortex, putamen, longitudinal follow-up
- MeSH terms
- Aged, Alzheimer Disease, Aniline Compounds, Atrophy, Brain, Carbon Radioisotopes, Cognition Disorders, Female, Follow-Up Studies, Humans, Male, Neuropsychological Tests, Thiazoles, Amyloid beta-Peptides, Disease Progression, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
